Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

溃疡性结肠炎 医学 安慰剂 内科学 随机对照试验 胃肠病学 结肠镜检查 灌肠 临床试验 移植 结直肠癌 疾病 病理 癌症 替代医学
作者
Sudarshan Paramsothy,Michael A. Kamm,Nadeem O. Kaakoush,Alissa Walsh,Johan van den Bogaerde,Douglas Samuel,Rupert W. Leong,Susan J. Connor,Watson Ng,Ramesh Paramsothy,Wei Xuan,Enmoore Lin,Hazel M. Mitchell,Thomas J. Borody
出处
期刊:The Lancet [Elsevier BV]
卷期号:389 (10075): 1218-1228 被引量:1067
标识
DOI:10.1016/s0140-6736(17)30182-4
摘要

Summary

Background

The intestinal microbiota is implicated in the pathogenesis of ulcerative colitis. Faecal microbiota transplantation is a novel form of therapeutic microbial manipulation, but its efficacy in ulcerative colitis is uncertain. We aimed to establish the efficacy of intensive-dosing, multidonor, faecal microbiota transplantation in active ulcerative colitis.

Methods

We conducted a multicentre, double-blind, randomised, placebo-controlled trial at three hospitals in Australia. We randomly allocated patients with active ulcerative colitis (Mayo score 4–10) in a 1:1 ratio, using a pre-established randomisation list, to either faecal microbiota transplantation or placebo colonoscopic infusion, followed by enemas 5 days per week for 8 weeks. Patients, treating clinicians, and other study staff were unaware of the assigned treatment. Faecal microbiota transplantation enemas were each derived from between three and seven unrelated donors. The primary outcome was steroid-free clinical remission with endoscopic remission or response (Mayo score ≤2, all subscores ≤1, and ≥1 point reduction in endoscopy subscore) at week 8. Analysis was by modified intention-to-treat and included all patients receiving one study dose. We performed 16S rRNA stool analysis to assess associated microbial changes. This trial is registered with ClinicalTrials.gov, number NCT01896635. The trial has ended; this report presents the final analysis.

Findings

From November, 2013, to May, 2015, 85 patients were enrolled to our trial, of whom 42 were randomly assigned faecal microbiota transplantation and 43 were allocated placebo. One patient assigned faecal microbiota transplantation and three allocated placebo did not receive study treatment and were excluded from the analysis. The primary outcome was achieved in 11 (27%) of 41 patients allocated faecal microbiota transplantation versus three (8%) of 40 who were assigned placebo (risk ratio 3·6, 95% CI 1·1–11·9; p=0·021). Adverse events were reported by 32 (78%) of 41 patients allocated faecal microbiota transplantation and 33 (83%) of 40 who were assigned placebo; most were self-limiting gastrointestinal complaints, with no significant difference in number or type of adverse events between treatment groups. Serious adverse events occurred in two patients assigned faecal microbiota transplantation and in one allocated placebo. Microbial diversity increased with and persisted after faecal microbiota transplantation. Several bacterial taxa were associated with clinical outcome; in particular, the presence of Fusobacterium spp was associated with lack of remission.

Interpretation

Intensive-dosing, multidonor, faecal microbiota transplantation induces clinical remission and endoscopic improvement in active ulcerative colitis and is associated with distinct microbial changes that relate to outcome. Faecal microbiota transplantation is, thus, a promising new therapeutic option for ulcerative colitis. Future work should focus on precisely defining the optimum treatment intensity and the role of donor–recipient matching based on microbial profiles.

Funding

Broad Medical Research Program, Gastroenterological Society of Australia, Mount Sinai (New York) SUCCESS fund, University of New South Wales.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
酷酷元风完成签到,获得积分10
1秒前
2秒前
天才幸运鱼完成签到,获得积分10
2秒前
3秒前
3秒前
粥游天下完成签到,获得积分10
4秒前
jcc完成签到,获得积分10
4秒前
哈哈哈哈完成签到,获得积分10
4秒前
lighthouse完成签到,获得积分10
5秒前
平凡中的限量版完成签到,获得积分10
5秒前
大伟完成签到,获得积分10
5秒前
long关注了科研通微信公众号
6秒前
懵懂的毛豆完成签到,获得积分10
6秒前
zzcherished发布了新的文献求助10
6秒前
zyq发布了新的文献求助10
6秒前
我是老大应助哦哦哦采纳,获得10
7秒前
YHY完成签到,获得积分10
7秒前
7秒前
天天呼的海角完成签到,获得积分10
10秒前
量子星尘发布了新的文献求助10
13秒前
13秒前
13秒前
jiangcai完成签到,获得积分10
14秒前
Cherry完成签到,获得积分10
16秒前
正能量的可可可完成签到,获得积分10
16秒前
tuo zhang发布了新的文献求助10
19秒前
草莓养乐多完成签到 ,获得积分10
19秒前
糊涂完成签到,获得积分10
19秒前
哦哦哦发布了新的文献求助10
19秒前
in完成签到 ,获得积分10
20秒前
pilot完成签到,获得积分10
22秒前
劣根完成签到,获得积分10
23秒前
Liang发布了新的文献求助20
23秒前
25秒前
26秒前
曾小莹完成签到,获得积分10
26秒前
苏信怜完成签到,获得积分10
27秒前
30秒前
大气灵枫发布了新的文献求助10
30秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029